Skip to main content

Day: January 18, 2024

DMG Blockchain Solutions Announces Operational Update

VANCOUVER, British Columbia, Jan. 17, 2024 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG” or the “Company”), a vertically integrated blockchain and cryptocurrency technology company, announces an operational update:New Mining Capacity: DMG is progressing with the deployment of approximately 36 megawatts of containerized mining capacity on its Christina Lake mining facility property. Concurrently, DMG has upgraded its mine network infrastructure to support the additional miners and add network redundancy.Miner Deployment Plan: The Company expects to be able to house both its ordered 4,550 units of new Bitmain T21 miners, which should generate approximately 1 EH/s of new hashrate capacity once installed and operating, as well as all of its more efficient legacy fleet,...

Continue reading

Mowi ASA (OSE:MOWI): Q4 2023 Trading update

Harvest volumes Q4 2023 (1)Farming Norway 81.0 thousand tonnesFarming Scotland 10.5 thousand tonnesFarming Chile 27.5 thousand tonnesFarming Canada 4.0 thousand tonnesFarming Ireland – thousand tonnesFarming Faroes 3.5 thousand tonnesFarming Iceland (Arctic Fish) 2.5 thousand tonnesTotal 129.0 thousand tonnes   Full year harvest volumes were record-high 475 thousand tonnes in 2023 versus 464 thousand tonnes in 2022. Note:(1) The harvest volumes are provided in gutted weight equivalents (GWE). Additional information Operational EBIT for the Group was approximately EUR 203 million in Q4 2023 (NOK 2.4 billion, NOKEUR 11.65) versus EUR 239 million in Q4 2022 (NOK 2.5 billion, NOKEUR 10.39). Blended farming cost was EUR 5.58 per kg in the quarter. Full year Operational EBIT in 2023 was record-high at approximately...

Continue reading

Lleida.net obtains three new patents in South America, reinforcing its innovative edge in electronic communications

Madrid, 18th January.- Lleida.net, a publicly traded Spanish company (OTCQX: OTC.US, Euronext Growth: ALLLN.PA, BME Growth: LLN.MA), has strengthened its leadership in electronic communications with the acquisition of three patents in South America.  The new patents granted in the region is as follows: 1. Brazil (11/21/2023): Patent No BR102015003034-7, entitled “Method for producing electronic contracts certified by a user of a telecommunications operator.” This patent focuses on streamlining the generation of electronic contracts, improving the reliability of digital transactions. 2. Uruguay (3/10/2023): Invention Patent No. 15350, under the name “Method for the Certification of Electronic Mail Containing a Recognized Electronic Signature by a Telecommunications Operator.” This technology improves the legal validity...

Continue reading

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

SHANGHAI, China, Jan. 17, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from the prespecified interim analysis for event-free survival (EFS) in patients with stage III non-Small Cell Lung Cancer (NSCLC) of NEOTORCH (NCT04158440) in the Journal of the American Medical Association (JAMA). NEOTORCH is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of toripalimab in combination with perioperative platinum-based chemotherapy vs chemotherapy alone in patients with resectable stage II or III NSCLC. NEOTORCH is the world’s first phase III clinical study...

Continue reading

MINILUXE ANNOUNCES OPTIONS GRANT

Issuance is part of normal course of incentive program for key team members and funded from existing employee option pool with no material dilution impact for shareholders Boston, MA, Jan. 17, 2024 (GLOBE NEWSWIRE) —  MiniLuxe Holding Corp. (the “Company”) (TSXV: MNLX) today announces that as part of its standard disclosures, the Company has granted 350,000 options to certain directors and officers of the Company at a strike price of CDN $0.48, which represents a premium of approximately ~10 percent to the prior day’s closing stock price. These option grants have no material dilution for shareholders, representing less than 25 basis points of the outstanding equity of the Company. On a fully diluted basis, the dilution impact is further mitigated by the cancellation of options from recent or planned exits of team members. The...

Continue reading

Rubicon Organics Grants DSUs and Options

VANCOUVER, British Columbia, Jan. 17, 2024 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, announces that it has granted 420,000 deferred share units (“DSUs”) and 15,000 stock options. DSU Grant The Company has granted an aggregate of 420,000 DSUs pursuant to the DSU plan to independent directors of the Company as compensation for their services in 2023. The DSUs vest immediately and may only be redeemed upon a holder ceasing to be a director of Rubicon Organics. Option Grant The Company has granted stock options for a total of 15,000 common shares to an employee of the Company pursuant to the equity incentive plan. The stock options are exercisable at $0.50 per share for a period...

Continue reading

Immatics Announces Pricing of $175 Million Public Offering

Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced today the pricing of an underwritten public offering of 15,925,000 ordinary shares at a public offering price of $11.00 per share. The gross proceeds from the offering, before deducting the underwriting discount and offering expenses, are expected to be approximately $175 million. The offering is expected to close on January 22, 2024, subject to customary closing conditions. In addition, Immatics has granted the underwriters a 30-day option to purchase up to 2,388,750 additional shares at the public offering price, less the underwriting discount. Jefferies, BofA Securities and Leerink Partners are acting...

Continue reading

Perlite Market worth $1.9 billion by 2025 Globally, at a CAGR of 6.3%, says MarketsandMarkets™

Chicago, Jan. 17, 2024 (GLOBE NEWSWIRE) — The Global Perlite Market size is estimated to grow from USD 1.4 billion in 2020 to USD 1.9 billion by 2025, at a CAGR of 6.3% during the forecast period, as per the recent study by MarketsandMarkets™. The growth of the construction and industrial applications plays a key role in driving the perlite market. Increasing demand from APAC will further drive the growth of the global perlite market. Browse in-depth TOC on “Perlite Market” 173 – Market Data Tables 43 – Figures 175 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219145595 List of Key Players in Perlite Market:Imerys Minerals (UK) Keltech Energies (India) Dupré Minerals (England) Amol Dicalite (India)Drivers, Opportunities and Challenges in Perlite Market:Drivers:...

Continue reading

SurgePays Announces Pricing of $15 Million Public Offering

BARTLETT, Tenn., Jan. 17, 2024 (GLOBE NEWSWIRE) — SurgePays, Inc. (Nasdaq: SURG) (“SurgePays”), a technology and telecom company focused on the underbanked and underserved communities, today announced that it has priced its previously announced underwritten public offering of 2,678,571 shares of its common stock at an offering price of $5.60 per share of common stock led by certain new and existing institutional investors. SurgePays has granted the underwriters a 45-day option to purchase up to 401,785 additional shares of its common stock sold in the offering on the same terms and conditions. The Company expects to close the offering on January 22, 2024, subject to customary conditions. Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the offering. The gross proceeds to...

Continue reading

Lowell Farms Inc. Announces Termination of the Zabala Road Lease

SALINAS, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born cannabis company with advanced production capabilities including extraction, manufacturing, and distribution, announces that on January 12, 2024, Cypress Holding Company, LLC (“Cypress”), a wholly owned subsidiary of the Company, surrendered possession of approximately 10 acres of real property at 139 Zabala Road, Salinas, California (the “Zabala Road Property”) leased by Cypress pursuant to a Lease Agreement dated April 1, 2017 (the “Zabala Road Lease”) with Tinhouse, LLC, dba Tinhouse Partners, LLC, as landlord (the “Landlord”). Prior to vacating the premises on January 12, 2024, the Company had operated a cultivation facility, which includes four greenhouses totaling approximately 255,000 square feet,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.